[Ip-health] Pharma Anti-Counterfeiting Conference, 30th June-2nd July, London

[James Love]

Does anyone know who at the WHO has made this claim?

* "The WHO estimates that 10% of global pharmaceutical commerce involves
counterfeits."


-------- Forwarded Message --------
From: Jacob Samek - Visiongain Ltd.
<pharma.conferences1@conferencesandreports.com>
Reply-To: pharma.conferences1@conferencesandreports.com
To: james.love@cptech.org
Subject: Pharma Anti-Counterfeiting Conference, 30th June-2nd July,
London
Date: Thu, 5 Jun 2008 04:41:37 +0100

=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
Pharmaceutical Anti-Counterfeiting Strategies Forum 2008
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
30th June, 1st & 2nd July 2008, BSG House, London

Worldwide sales of counterfeit drugs could nearly double to $75bn
(=E2=82=AC60bn, =C2=A340bn) by 2010, according to the Center for Medicine i=
n the
Public Interest. In some developing countries more than 50 per cent of
the drug supply is said to be counterfeit. There needs to be greater
discussion within the industry about how to fight this problem. That is
why the industry has made the decision to come together, meet and
discuss how to tackle this dangerous issue as a united body.

RFID, bar coding, holograms, and colour-shifting inks are very well
known as methods of combating pharmaceutical counterfeiting. But the
industry is constantly in search of innovative strategies to stay ahead
of the fraudsters. Where the industry hears about the latest techniques
and strategies is at the Annual Pharmaceutical Anti-Counterfeiting
Strategies Conference. Will you be attending next year? If you want to
hear about some of the latest strategies such as transparent laser
markings of encrypted code on single product items, or new finger print
technologies, or the latest in surface authentication systems, then
really you need to be there.

The last five years have seen an explosive growth in counterfeit
prescription drugs that is showing no signs of relenting. This has a
serious impact on your profit margins and poses a direct threat by
putting patient=E2=80=99s lives at risk. The WHO estimates that 10% of glob=
al
pharmaceutical commerce involves counterfeits. International crime
syndicates are becoming more sophisticated and better organised in
counterfeiting. Is this problem at risk of spiralling out of control?
Many analysts believe so with counterfeiting expected to reach 20 per
cent by the 2010. They believe that as a result, counterfeiting will
jeopardize fundamental trust in the pharmaceutical industry. So why is
the industry waiting for a catastrophic failure before confronting
inherent weaknesses in the system? Many aren't and the first step they
are taking is to meet and discuss how the industry can fight back. And
where they are meeting is in London from the 24th - 26th January. You
must attend.

The Annual Anti-counterfeiting Strategies Forum will enable global
regulatory bodies, pharmaceutical, security and anti-counterfeiting
companies to come together to discuss and plan a regulatory commercial
strategy to tackle this critical problem. So how will the industry seek
to identify the most effective countermeasures to manage risk, minimize
brand erosion and loss of sales? Book your place now so that you can put
you and your company=E2=80=99s voice forward in this Annual Forum.

The international conference will cover themes of:
- Routes to enabling cross-border co-operation with international
security organisations
- Implementation of the latest tamper-proof and automatic drug recall
technology
- Enhancing supply chain security through new configurations in existing
technology
- Ancillary benefits of improved systems for inventory and distribution


Speakers include:
* Andrew Jackson, Deputy Global Head, Corporate Security, Novartis
* Janice Kite, Project Manager Traceability in Healthcare, GS1
* Andrew Jenner, Head of IP Crime Policy, UK Intellectual Property
Office
* Christopher Stothers, Associate, Intellectual Property Practice Group,
Millbank, Tweed, Hadley and McCloy
* Monika Derecque-Pois, Secretary General, GIRP
* Eric Noehrenberg, Director, International Trade & Market Policy,
International Federation of Pharmaceutical Manufacturers Associations
* Jim Thomson, CEO, Centre for Mental Health
* Christine H=C3=A4nle, Corporate Purchasing Ethical Manager, Celesio
* Leam Thompson, In house Counsel, Asset Investigation & Confiscation,
BDO Stoy Hayward
* Heinz Kobelt, Secretary General, European Association
Euro-Pharmaceutical Companies


Key benefits of attending
- Identifying the scale of the problem and the drugs most commonly
counterfeited
- Discover the legal issues surrounding counterfeit drugs
- Gaining insight to the market effects of parallel trading and ways to
regulate it
- Enhancing detection methods of fake products and ultimately deter
counterfeiting
- Minimizing the harm to brand name from market recall incidents

How will you benefit from attending this event?
* Meet your peers to discuss and shape the future strategies the
industry plans to take
* Network with senior representatives from Global regulatory bodies as
well as major pharmaceutical companies and hear how they plan to tackle
the industry wide problem
* Gain an up-to-date overview and understanding of the most vital
concerns in the battle against counterfeiters
* Learn how to achieve a competitive edge and mitigate risks through an
active approach with procedures to safeguard against counterfeiting
* Explore partnership opportunities between technology providers and
pharmaceutical corporations to enhance security of the supply chain

If you only attend one event this year make sure it is the conference
that will guarantee your success for the next few years. Places at this
conference are limited and are issued on a strict first come, first
served basis. Contact me now to reserve your seat.


________________________________________________________________________

Sponsorship and exhibition opportunities:

If you would like benefit by promoting your organisation at one of our
events then exhibiting is perfect for you.
- Network with industry decision-makers
- Increase and maintain brand awareness
- Meet potential clients face to face
- Target your marketing campaign
- Present your latest products and ideas

Places at this global forum are by invitation only. The Annual
Pharmaceutical Anti-counterfeiting Strategies Forum is growing each year
as members of the industry meet and benefit from the forum of open
discussion and networking. It is by tackling the problem together that
we hope to combat and rid the industry of the dangers of counterfeit
drugs. I would like to extend this invitation to attend to you and would
request that you contact us now to register your attendance. We can then
dispatch your booking confirmation and letter of approval.

________________________________________________________________________
Who should attend:
- Pharmaceutical companies
- Pharmaceutical distributors
- Government health departments
- Public health and regulatory bodies
- Law enforcers =E2=80=93 police, customs agencies, investigative firms
- Non-government healthcare organisations
- Pharmaceutical associations
- Converters, packaging and labelling companies
- Authentication technology suppliers

Job titles: Directors, Heads and Managers of:
- Supply Chain and Distribution
- Packaging and Labeling
- Compliance
- Security
- Information Systems
- Regulatory Affairs
- R&D
- Business Development and Marketing
- Product Information
- Standards
- Patient Safety
- Pharmaceuticals/Life Sciences Analyst or
- Business Development
- Marketing
- Sales
- Security managers

________________________________________________________________________
Conference Agenda

Pre Conference Workshop, 30th June, Monday

Recent Trends in International Counterfeiting


Will include topics such as:
=E2=80=A2 Transit shipments after Diesel v Montex
=E2=80=A2 Liability of carriers/freight forwarders


Daniel Marschollek, Partner, Mayer Brown


Day One, 1st July, Tuesday
08:30 Refreshments and registration

09:30 Registration and refreshments

10:00 Opening address from the chair
- Eric Noehrenberg, Director, International Trade & Market Policy,
International Federation of Pharmaceutical Manufacturers Associations

10:10 A global strategy to fight counterfeiting
=E2=80=A2 A safe and secure supply chain
=E2=80=A2 Authentication and traceability
=E2=80=A2 Activities of regulatory bodies and industry worldwide
=E2=80=A2 Global standards =E2=80=93 how do they help fighting counterfeiti=
ng?

Janice Kite, Project Manager Traceability in Healthcare, GS1

10:50 Technological and non-technological measures
- How can we protect patients?
=E2=80=A2 Product coding and identifications as pre-requisite for tracking =
and
tracing
=E2=80=A2 Bar codes versus RFID
=E2=80=A2 EU versus US: are the approaches different?
=E2=80=A2 Stake holder and government initiatives

- Monika Dereque-Pois, Director General, GIRP

11:30 Morning refreshments

11:50 The costs of counterfeit drugs
=E2=80=A2 The burden on the health care system
=E2=80=A2 Financial damage due to loss of sales and a reduced return on R&D
investments
=E2=80=A2 The cost of a damaged brand

- Paul Forster-Jones, Managing Director, Cordia Healthcare, Board
Member, UniChem

12:30 Stake holder and government initiatives combating counterfeits of
medicinal products
=E2=80=A2 The size of the problem
=E2=80=A2 The technological approach
=E2=80=A2 The logistical approach
=E2=80=A2 Global asset tracing: identification of conduct & property

- Tassilo Korab, Executive Director, Health Compliance Packaging Council

13:10 Networking lunch

14:30 The changes in European policy
=E2=80=A2 Protecting IP rights
=E2=80=A2 Is the European Union finally combating counterfeiters?
=E2=80=A2 What will be the end result?

15:10 The UK national IP crime strategy
=E2=80=A2 The difference between industry sectors and IP crime
=E2=80=A2 How pursing IP infringements can deter pharmaceutical counterfeit=
ing

- Andrew Jenner, Head of IP Crime Policy, UK Intellectual Property
Office

15:50 Afternoon refreshments

16:10 Closing the Security Loop: Extending E-Pedigree From Package to
Patient
=E2=80=A2 Counterfeiting of medications continues to escalate and is estima=
ted
to
reach $75 billion by 2010
=E2=80=A2 Most Brand Protection and E-Pedigree solutions focus on ON-Packag=
e
solutions such as RFID and 2-D bar coding
=E2=80=A2 On-Package solutions are deemed effective but are lost once produ=
ct is
repackaged or if the product is separated from its original packaging, a
common occurrence in today=E2=80=99s world
=E2=80=A2 To close the loop on product security, On-Dosage technologies tha=
t
complement
On-Package solutions should be employed to extend protection to the
patient
=E2=80=A2 Combined with a pro-active product sampling program at the retail
level, On-
Dosage technologies can provide an =E2=80=9CEarly Warning=E2=80=9D system f=
or
counterfeits
and illegal diversion, allowing Pharmaceutical Manufacturers to strike
back at
those who steal their profits at the expense of patient=E2=80=99s well-bein=
g and
safety

- Dean Hart, Executive Vice President Comersial Operations, Nanoink

16:30 Panel discussion: Fighting the fakes =E2=80=93 To choose a combat str=
ategy
=E2=80=A2 Should we focus on technology, legislation or a logistic approach=
?
=E2=80=A2 Will tracking and tracing keep the supply chain safe?
=E2=80=A2 Are the various efforts to combat counterfeiters coordinated enou=
gh?

17:10 Closing remarks from the chair

17:15 Networking drinks
Take your discussions further and build new relationships in a relaxed
and informal setting

Day Two, 2nd July, Wednesday
09:30 Registration and refreshments

10:00 Opening address from the chair

Eric Noehrenberg, Director, International Trade & Market Policy,
International Federation of Pharmaceutical Manufacturers Associations

10:10 Defending brands & pursuing offenders: The identification,
pursuit, management & recovery of the proceeds of counterfeiting
=E2=80=A2 Deterrents & disruption
=E2=80=A2 Exploration of existing legislative provision to recover the proc=
eeds
of counterfeiting
=E2=80=A2 Alternative civil remedies
=E2=80=A2 Global asset tracing: identification of conduct & property

- Leam Thompson, In house Counsel, Asset Investigation & Confiscation,
BDO Stoy Hayward

10:50 Presentation to be announced

- Cindy M=C3=BCller, President, Bilcare Europe

11:30 Morning refreshments

11:50 Anti-Counterfeiting technologies in the pharmaceutical industry =E2=
=80=93
How to be effective
=E2=80=A2 Understanding the pharmaceutical protection requirements
=E2=80=A2 The multi-layer approach
=E2=80=A2 Technologies, applications and success stories
=E2=80=A2 Tracing, e-pedigree and online-authentication
=E2=80=A2 Pre-requisites of a successful brand protection campaign

- Thomas Voelcker, Director Marketing and Sales, Schreiner ProSecure

12:30 Supply chain security =E2=80=93 the logistic view
=E2=80=A2 Are anti-counterfeiting strategies interfering with the logistics=
 of
the
supply chain?
=E2=80=A2 Examining the impact of different strategies on the supply chain
=E2=80=A2 Technology and logistics =E2=80=93 how can you use anti-counterfe=
iting to aid
logistics

- Mark Harvey, Head of Security, NYK Logistics

13:10 Networking lunch

14:30 Counterfeit drugs on the internet
=E2=80=A2 The relevance of consumer education as a part of the strategy to =
fight
counterfeit drugs
=E2=80=A2 Advertising on the internet
=E2=80=A2 Monitor internet pharmacies arranging supply chains against
counterfeits and diversion through on-line purchases

- Andrew Jackson, Deputy Global Head, Corporate Security, Novartis

15:10 The reality of internet pharmacies
=E2=80=A2 Presenting a study of the quality of drugs bought of the internet
=E2=80=A2 Buying medicine over the internet; where does the money go?

- Jim Thomson, CEO, Centre for Mental Health

15:50 Afternoon refreshments

16:10 Parallel trade and counterfeit pharmaceuticals
=E2=80=A2 The current framework for parallel trade and repackaging of
pharmaceuticals
=E2=80=A2 Discovery of counterfeit pharmaceuticals in the parallel supply c=
hain
=E2=80=A2 Actual and proposed changes to the distribution and parallel trad=
e
framework

- Christopher Stothers, Associate, Intellectual Property Practice Group,
Milbank, Tweed, Hadley and McCloy

16:50 The contribution of parallel trade distribution to a safe supply
chain
=E2=80=A2 While legal in the EU/EEA area, PT is often perceived by manufact=
urers
(although not by regulators) as a weakening of the distribution chain
=E2=80=A2 The EAEPC argues that its members provide identical medicines at =
lower
cost than manufacturers=E2=80=99 prices to patients and final payers. Membe=
rs
share with manufacturers the objective of fighting against counterfeits
and raising the barriers to keep these out of the legitimate supply
chain
=E2=80=A2 This presentation looks at the regulatory environment for paralle=
l
distribution and looks at the rigorously controlled business practices
of re-packaging/re-labelling, and will demonstrate the safety profile of
the industry. The presentation will address ways to improve the supply
chain without jeopardizing the freedom of movement of pharmaceutical
goods across Europe.

- Heinz Kobelt, Secretary General, European Association
Euro-Pharmaceutical Companies

17:30 Chair=E2=80=99s closing remarks

________________________________________________________________________
List of upcoming events

You may be also interested in attending other events Visiongain
organises. Below you can find list of these events.
If you would like to receive more information, do not hesitate
contacting me.

3rd Annual Pharmacovigilance
11th - 13th June 2008, London, UK

Dissolution Testing, Bioequivalence and Bioavailability Strategies
26th - 27th June 2008, London, UK

In Vitro-in Vivo Correlation (IVIVC) Training Course
22nd July, London, UK

Lyophilisation for Pharmaceuticals 2008
3rd - 5th September, London, UK

2nd Annual Optimising Stability Testing
17th - 19th September, London, UK

Obesity Drug Development Colloquium
24th - 26th September 2008, London, UK


________________________________________________________________________

- PRICING -
- 3 day Conference ticket (inc. pre-conference workshop) - available for
only GBP =C2=A3999 (NORMAL PRICE =C2=A31699)
- 2 day Conference ticket - available for only GBP =C2=A3799 (NORMAL PRICE
=C2=A31299)
- Pre-conference workshop only - GBP =C2=A3599

If you would like to send more than 1 person then take advantage of the
3 for 2 offer. Send 3 people but only pay for 2

Excellent networking opportunities.

- ORDERING -
Ordering is simple! All you need to book your place is contact Jacob
today. You can either email me at
pharma.conferences1@conferencesandreports.comor call on TEL: +44 (0)207
549 9971.

Kind regards,

Jacob Samek
Visiongain Ltd.
4th Floor,
BSG House,
226-236 City Road,
London
EC1V 2QY
United Kingdom


________________________________________________________________________